EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nucleoside analogues in etiotropic therapy of hantavirus fevers

A N Vetrova iD, S S Kurashova iD, M S Egorova iD, T K Dzagurova iD

Problems of Virology · 2026

DOI: 10.36233/0507-4088-405 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Problems of Virology, 2026. Verfasst von A N Vetrova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliom…. Hauptthemen laut MEDLINE: Antiviral Agents, Orthohantavirus, Nucleosides, Hemorrhagic Fever with Renal Syndrome. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hantavirus fevers (HF) are caused by pathogenic orthohantaviruses and are classified into two clinical forms: hemorrhagic fever with renal syndrome (HFRS), reported in Eurasia, and hantavirus pulmonary syndrome (HPS), reported in the Americas. HF are characterised by an acute course with predominant involvement of internal organs: HFRS is mainly associated with kidney damage, while HPS is characterised by severe lung injury. Both diseases may also affect the central nervous and endocrine systems. In addition, hantavirus fevers are marked by severe complications during the acute phase and a prolonged recovery period. Currently, there is neither a WHO-approved vaccine nor any effective etiotropic anti-hantavirus therapy. The development of antiviral treatment strategies focuses on preventing orthohantavirus entry into cells or suppressing their intracellular replication. One of the main directions in the search for effective anti-hantavirus therapy is the low-molecular-weight compounds development and testing, many of which have demonstrated pronounced antiviral activity against orthohantaviruses through direct or indirect effects on viral RNA polymerase function. The review shows that new antiviral nucleoside compounds development and study has promising potential, as well as their combined use for effective etiotropic, pathogenetic and symptomatic treatment of hantavirus fevers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsOrthohantavirusNucleosidesHemorrhagic Fever with Renal SyndromeHantavirus Pulmonary SyndromeHantavirus InfectionsHumansAnimalsVirus Replication

Stichwörter der Autor:innen

ETARHFRSamantadineantiviral agentsantiviral compoundsfavipiravirhantavirus infectionshemorrhagic fever with renal syndromereviewribavirinselenazofurinzidovudine

Substanzen

Antiviral AgentsNucleosides

Autor:innen und Institutionen

  • Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis).

ORCID-Profile: A N Vetrova, S S Kurashova, M S Egorova, T K Dzagurova

Zitieren

APA

Vetrova, A. N., Kurashova, S. S., Egorova, M. S., & Dzagurova, T. K. (2026). Nucleoside analogues in etiotropic therapy of hantavirus fevers. Problems of Virology. https://doi.org/10.36233/0507-4088-405

Vancouver

Vetrova AN, Kurashova SS, Egorova MS, Dzagurova TK. Nucleoside analogues in etiotropic therapy of hantavirus fevers. Problems of Virology. 2026. doi:10.36233/0507-4088-405

BibTeX
@article{Vetrova2026,
  author = {Vetrova, A N and Kurashova, S S and Egorova, M S and Dzagurova, T K},
  title = {Nucleoside analogues in etiotropic therapy of hantavirus fevers},
  journal = {Problems of Virology},
  year = {2026},
  doi = {10.36233/0507-4088-405}
}
Kostenlos starten →